FindTrial
Sign In

Glanular part of newly constructed urethra during hypospadias repair - does it require a vascular flap cover ?

Risk of Complications associated with Vascular Flap Coverage of Glanular Neourethra during Primary Urethroplasty â?? A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/01/011304
Enrollment
130
Registered
2018-01-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- All cases of hypospadias for primary urethroplasty (including distal penile, mid penile, and proximal penile hypospadias without chordee) admitted in our Department are eligible for this study.

Interventions

Intervention1: Group A: No flap coverage of glanular neourethra Control Intervention1: Group B: Dartos / TVT flap coverage of glanular neourethra

Sponsors

Nonfunded
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All cases of hypospadias for primary urethroplasty (including distal penile, mid penile, and proximal penile hypospadias without chordee) admitted in our Department are eligible for this study

Exclusion criteria

Exclusion criteria: All cases of re-do urethroplasty or staged urethroplasty will not be considered for this study.

Design outcomes

Primary

MeasureTime frame
To determine glanular complications (meatal stenosis, glanular dehiscence, glanular urethral stricture) after primary urethroplasty with and without vascular flap coverage of glanular neourethra.Timepoint: 6 months of followup.—

Secondary

MeasureTime frame
To determine the incidence of urethrocutaneous fistula (glanular or subcoronal) after primary urethroplasty with and without vascular flap coverage of glanular neourethra.Timepoint: 6 months of followup.;To determine the maximal versus minimal glans width impacting the outcome of glans dehiscenceTimepoint: 6 months of followup.—

Countries

India

Contacts

Public ContactDr Manoj Kumar Mohanty

All India Institute of Medical Sciences, Bhubaneswar

manoj65us@yahoo.com9438884101

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026